TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,689,000 | -75.8% | 56,388 | -66.3% | 0.00% | -76.5% |
Q3 2021 | $11,103,000 | -14.9% | 167,145 | -0.0% | 0.02% | -15.0% |
Q2 2021 | $13,042,000 | +147.2% | 167,159 | +199.8% | 0.02% | +122.2% |
Q1 2021 | $5,275,000 | -20.9% | 55,759 | +1.9% | 0.01% | -25.0% |
Q4 2020 | $6,666,000 | – | 54,705 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |